R. Dudenhofer

CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease

L. Crofford, A. Barnado, Joyce E. Johnson, 2021, Clinical and Experimental Medicine.

A Phase I Randomized, Controlled, Clinical Trial of Valganciclovir in Idiopathic Pulmonary Fibrosis

Pingsheng Wu, J. Loyd, L. Lancaster, 2021 .

Anti-tRNA synthetase syndrome interstitial lung disease: A single center experience

L. Crofford, A. Barnado, N. Annapureddy, 2021, medRxiv.